Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 

Online Report Subscribers, Click Here
Pricing and Ordering Information

  

European Markets for Nonvascular Stents
Report #A253 - January 2012
111 Pages – 27 Exhibits – 8 Company Profiles

In recent years, there have considerable advances both in product design and materials used for all forms of nonvascular stents. Significant changes in the structure and design of nonvascular stents have been made through proprietary technologies, which have helped prevent stent migration and improve flexibility. In 2010, nonvascular stents (including biliary, esophageal, trachobronchial, and urologic) stents were used in more than 56,550 interventional procedures in the countries covered by this report (France, Germany, Italy, Spain, and the United Kingdom), generating nearly $93 million in associated product sales. Over the forecast period covered by this report, the number of nonvascular stenting procedures performed in Europe is expected to increase at a 3.1% growth rate, reaching nearly 65,790 in the year 2015; during the same period, corresponding dollar sales are expected to increase at a 6.4% growth rate, reaching approximately $126 million in the year 2015.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European nonvascular stents market. Major topics covered by this report include a discussion of current and emerging nonvascular stenting technologies; a clinical overview of nonvascular conditions targeted by stenting, and an analysis of the European markets for biliary, esophageal, tracheobronchial, and urologic (including ureteral and urethral/prostatic) stents.

Ordering Information

Title

 Report# Publication
Date		 List Price

European Markets for Nonvascular Stents

A253

January 2012

$4,850
Order Online:
Single User only (Please call for corporate subscription pricing)		 PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

i.      Stent Design

ii.     Procedure Volumes

iii.    Market Analysis

a.   Biliary Stents

b.   Esophageal Stents

c.   Tracheobronchial Stents

d.   Urologic Stents

e.   Combined Market Forecast

 

Exhibit ES-1:    Europe, Nonvascular Stent Placements, Combined Procedure Volumes Forecast, 2010-2015

Exhibit ES-2:    Europe, Nonvascular Stents, Combined Market Forecast, 2010-2015

 

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

1.1 Stent Design

1.1.1 Vascular Stents

1.1.2 Nonvascular Stents

1.1.3 Stent Deployment Mechanisms

1.2 Stent Materials

1.2.1 Metal

1.2.1.1 Absorbable Magnesium Alloys

1.2.1.2 Cobalt Alloys

1.2.1.3 Nickel-Titanium Alloys

1.2.1.4 Stainless Steel

1.2.2 Standard Polymers

1.2.3 Biodegradable Polymers

1.3 Stent Coatings

1.3.1 Radiopacity Enhancement

1.3.2 Biocompatibility Enhancement

1.3.3 Active Therapeutic Enhancement

1.3.3.1 Drug-Eluting Stents

1.3.3.1.1 Antirestenotic Efficacy

1.3.3.1.2 Drug Delivery Techniques

1.3.4 Stent Coverings and Linings

 

Exhibit 1-1:      Selected Biomedical, Clinical, and Technical Stent Requirements

Exhibit 1-2:      Advantages and Disadvantages of Selected Vascular Stent Designs

Exhibit 1-3:      Advantages and Disadvantages of Metal Stent Materials

Exhibit 1-4:      Selected Polymeric Stent Materials

Exhibit 1-5:      Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents

Exhibit 1-6:      Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents

 

2. OVERVIEW OF STENTING FOR NONVASCULAR APPLICATION

2.1 Bile Duct Diseases

2.1.1 Benign Biliary Strictures

2.1.2 Malignant Biliary Strictures

2.1.3 Treatment

2.2 Esophageal Diseases

2.2.1 Benign Esophageal Strictures

2.2.2 Malignant Esophageal Strictures

2.2.3 Treatment

2.2.3.1 Nonsurgical Treatment

2.2.3.2 Surgical Treatment

2.3 Renal System Diseases

2.3.1 Benign Urethral and Prostatic Strictures

2.3.2 Malignant Urethral and Prostatic Strictures

2.3.3 Treatment

2.4 Tracheobronchial System Diseases

2.4.1 Benign Tracheobronchial Strictures

2.4.2 Malignant Tracheobronchial Strictures

2.4.3 Treatment

2.4.3.1 Expandable Metal Stents

2.4.3.2 Silicone Stents

 

3. EUROPEAN NONVASCULAR STENTS MARKET

3.1 Biliary Stents

3.1.1 Products and Technologies

3.1.2 Market Analysis

3.1.3 Competitive Analysis

3.2 Esophageal Stents

3.2.1 Products and Technologies

3.2.2 Market Analysis

3.2.3 Competitive Analysis

3.3 Tracheobronchial Stents

3.3.1 Products and Technologies

3.3.2 Market Analysis

3.3.3 Competitive Analysis

3.4 Urologic Stents

3.4.1 Products and Technologies

3.4.1.1 Ureteral Stents

3.4.1.2 Urethral (or Prostatic) Stents

3.4.2 Market Analysis

3.4.3 Competitive Analysis

3.5 Combined Market Analysis

3.5.1 Market Drivers

3.5.2 Market Limiters

3.5.3 Combined Market Forecast

 

Exhibit 3-1:      2012, Europe, Selected Biliary Stents

Exhibit 3-2:      Europe, Biliary Stent Placements, Procedure Volumes Forecast, 2010-2015

Exhibit 3-3:      Europe, Biliary Stents, Market Forecast, 2010-2015

Exhibit 3-4:      2010, Europe, Biliary Stents Market, Share by Supplier

Exhibit 3-5:      2012, Europe, Selected Esophageal Stents

Exhibit 3-6:      Europe, Esophageal Stent Placements, Procedure Volumes Forecast, 2010-2015

Exhibit 3-7:      Europe, Esophageal Stents, Market Forecast, 2010-2015

Exhibit 3-8:      2010, Europe, Esophageal Stents Market, Share by Supplier

Exhibit 3-9:      Advantages and Disadvantages of Metal and Silicone Tracheobronchial Stents

Exhibit 3-10:    2012, Europe, Selected Tracheobronchial Stents

Exhibit 3-11:    Europe, Tracheobronchial Stent Placements, Procedure Volumes Forecast, 2010-2015

Exhibit 3-12:    Europe, Tracheobronchial Stents, Market Forecast, 2010-2015

Exhibit 3-13:    2010, Europe, Tracheobronchial Stents Market, Share by Supplier

Exhibit 3-14:    2012, Europe, Selected Urologic Stents

Exhibit 3-15:    Europe, Urologic Stent Placements, Procedure Volumes Forecast, 2010-2015

Exhibit 3-16:    Europe, Urologic Stents, Market Forecast, 2010-2015

Exhibit 3-17:    2010, Europe, Urologic Stents Market, Share by Supplier

Exhibit 3-18:    Europe, Nonvascular Stent Placements, Combined Procedure Volumes Forecast, 2010-2015

Exhibit 3-19:    Europe, Nonvascular Stents, Combined Market Forecast, 2010-2015

 

4. COMPANY PROFILES

4.1       Abbott Laboratories

4.2       C.R. Bard, Inc.

4.3       Boston Scientific Corporation

4.4       Cook Group, Inc.

4.5       ev3, Inc./Covidien, Inc.

4.6       W.L. Gore & Associates, Inc.

4.7       Johnson & Johnson

4.8       Medtronic, Inc.

 

APPENDIX:  COMPANY LISTING

 

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact reports@elsevier.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home